This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cavallo, J.-D.
Right arrow Articles by Hernandez, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavallo, J.-D.
Right arrow Articles by Hernandez, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2002, p. 2307-2309, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2307-2309.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Antibiotic Susceptibilities of 96 Isolates of Bacillus anthracis Isolated in France between 1994 and 2000

Jean-Didier Cavallo,1 Francoise Ramisse,2 Monique Girardet,1 Josée Vaissaire,3 Michelle Mock,4 and Eric Hernandez1*

Laboratoire de Biologie Médicale, Hôpital d'Instruction des Armées Bégin, 94163 Saint-Mandé,1 Laboratoire de Microbiologie, Centre d'Etudes du Bouchet, 91710 Vert-le-Petit,2 Laboratoire de l'Afssa Lerpaz, Unité des Zoonoses Bactériennes, 94700 Maisons Alfort,3 Institut Pasteur, Unité des Toxines et Pathogénie Bactérienne, CNRS URA2172, 75015 Paris, France4

Received 28 January 2002/ Returned for modification 28 February 2002/ Accepted 1 April 2002

Ninety-six isolates of Bacillus anthracis recovered in France between 1994 and 2000 were tested for their susceptibilities to 25 different antibiotics. Resistance to penicillin G and amoxicillin was 11.5%. All of the isolates were resistant to cotrimoxazole and susceptible to doxycycline, ciprofloxacin, pefloxacin, levofloxacin, teicoplanin, vancomycin, clindamycin, imipenem, and rifampin.

* Corresponding author. Mailing address: HIA Bégin, 69 Avenue de Paris, 94163 Saint-Mandé Cedex, France. Phone: (33) 1 43 98 47 33. Fax: (33) 1 43 98 53 36. E-mail: hnz.eric{at}freesurf.fr.

Antimicrobial Agents and Chemotherapy, July 2002, p. 2307-2309, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2307-2309.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Barrow, E. W., Dreier, J., Reinelt, S., Bourne, P. C., Barrow, W. W. (2007). In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant Bacillus anthracis. Antimicrob. Agents Chemother. 51: 4447-4452 [Abstract] [Full Text]  
  • Luna, V. A., King, D. S., Gulledge, J., Cannons, A. C., Amuso, P. T., Cattani, J. (2007). Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre(R) automated microbroth dilution and Etest(R) agar gradient diffusion methods. J Antimicrob Chemother 60: 555-567 [Abstract] [Full Text]  
  • Kao, L. M., Bush, K., Barnewall, R., Estep, J., Thalacker, F. W., Olson, P. H., Drusano, G. L., Minton, N., Chien, S., Hemeryck, A., Kelley, M. F. (2006). Pharmacokinetic Considerations and Efficacy of Levofloxacin in an Inhalational Anthrax (Postexposure) Rhesus Monkey Model. Antimicrob. Agents Chemother. 50: 3535-3542 [Abstract] [Full Text]  
  • Maho, A., Rossano, A., Hachler, H., Holzer, A., Schelling, E., Zinsstag, J., Hassane, M. H., Toguebaye, B. S., Akakpo, A. J., Van Ert, M., Keim, P., Kenefic, L., Frey, J., Perreten, V. (2006). Antibiotic Susceptibility and Molecular Diversity of Bacillus anthracis Strains in Chad: Detection of a New Phylogenetic Subgroup.. J. Clin. Microbiol. 44: 3422-3425 [Abstract] [Full Text]  
  • Holty, J.-E. C., Bravata, D. M., Liu, H., Olshen, R. A., McDonald, K. M., Owens, D. K. (2006). Systematic review: a century of inhalational anthrax cases from 1900 to 2005.. ANN INTERN MED 144: 270-280 [Abstract] [Full Text]  
  • Barrow, E. W., Bourne, P. C., Barrow, W. W. (2004). Functional Cloning of Bacillus anthracis Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim. Antimicrob. Agents Chemother. 48: 4643-4649 [Abstract] [Full Text]  
  • Chen, Y., Tenover, F. C., Koehler, T. M. (2004). {beta}-Lactamase Gene Expression in a Penicillin-Resistant Bacillus anthracis Strain. Antimicrob. Agents Chemother. 48: 4873-4877 [Abstract] [Full Text]  
  • Grohs, P., Podglajen, I., Gutmann, L. (2004). Activities of Different Fluoroquinolones against Bacillus anthracis Mutants Selected In Vitro and Harboring Topoisomerase Mutations. Antimicrob. Agents Chemother. 48: 3024-3027 [Abstract] [Full Text]  
  • Turnbull, P. C. B., Sirianni, N. M., LeBron, C. I., Samaan, M. N., Sutton, F. N., Reyes, A. E., Peruski, L. F. Jr. (2004). MICs of Selected Antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a Range of Clinical and Environmental Sources as Determined by the Etest. J. Clin. Microbiol. 42: 3626-3634 [Abstract] [Full Text]  
  • Athamna, A., Athamna, M., Abu-Rashed, N., Medlej, B., Bast, D. J., Rubinstein, E. (2004). Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother 54: 424-428 [Abstract] [Full Text]  
  • Steward, J., Lever, M. S., Simpson, A. J. H., Sefton, A. M., Brooks, T. J. G. (2004). Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones. J Antimicrob Chemother 54: 95-99 [Abstract] [Full Text]  
  • Huang, W., Beharry, Z., Zhang, Z., Palzkill, T. (2003). A broad-spectrum peptide inhibitor of {beta}-lactamase identified using phage display and peptide arrays. Protein Eng Des Sel 16: 853-860 [Abstract] [Full Text]  
  • Price, L. B., Vogler, A., Pearson, T., Busch, J. D., Schupp, J. M., Keim, P. (2003). In Vitro Selection and Characterization of Bacillus anthracis Mutants with High-Level Resistance to Ciprofloxacin. Antimicrob. Agents Chemother. 47: 2362-2365 [Abstract] [Full Text]  
  • Materon, I. C., Queenan, A. M., Koehler, T. M., Bush, K., Palzkill, T. (2003). Biochemical Characterization of {beta}-Lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob. Agents Chemother. 47: 2040-2042 [Abstract] [Full Text]  
  • Chen, Y., Succi, J., Tenover, F. C., Koehler, T. M. (2003). {beta}-Lactamase Genes of the Penicillin-Susceptible Bacillus anthracis Sterne Strain. J. Bacteriol. 185: 823-830 [Abstract] [Full Text]  
  • Drago, L., De Vecchi, E., Lombardi, A., Nicola, L., Valli, M., Gismondo, M. R. (2002). Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates. J Antimicrob Chemother 50: 1059-1063 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»